Skip to main content

Overall Strategy

  • Chapter

Abstract

The first requirement in tackling this broad subject is a satisfactory definition of strategy. Since the subject concerns the war against gallstone disease, and since this book is an international undertaking, we thought it appropriate to consult the writings of a famous military strategist, Von Clausewitz. He states that ‘die Strategie ist der Gebrauch des Gefechts zum Zweck des Krieges’. This is translated as ‘strategy is the use of battles for the object of the war’. Thus, strategy consists of relating methods to a clearly defined object. We would define the object of the war against gallstone disease as being ‘to ensure that as many gallstone patients as possible are maintained free of gallstones in the long term’. In order to achieve this object, we have at present three non-surgical methods that we can use - a physical approach (fragmentation therapy or extracorporeal shock wave lithotripsy), a chemical approach (the use of chemical solvents, in particular methyl tert-butyl ether) and a physico-chemical approach (bile acid therapy using chenodeoxycholic acid (CDCA) and/or ursodeoxycholic acid UDCA)).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ransohoff, D.F. (1985). Natural history of silent gallstones. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Enterohepatic Circulation of Bile Acids and Sterol Metabolism. pp. 277–84 (Lancaster: MTP Press)

    Google Scholar 

  2. Attili, A.F. (1986). Natural history and prevention. In Bateson, M. (ed.) Gallstone Disease and its Management, pp. 57–70. (Lancaster: MTP Press)

    Google Scholar 

  3. Paumgartner, G. (1988). In Northfield, T.C., Jazrawi, R. and Zentler-Munro, P.L. (eds.) Bile Acids in Health and Disease. Ch. 15. (Lancaster: MTP Press)

    Google Scholar 

  4. Thistle, J.L. (1988). In Northfield, T.C., Jazrawi, R. and Zentler-Munro, P.L. (eds.) Bile Acids in Health and Disease Ch. 14. (Lancaster: MTP Press)

    Google Scholar 

  5. Hospital in-patient enquiry, 1985. Series HB4 No. 27. DHSS Office of Population Censuses and Surveys. HMSO London, 1987

    Google Scholar 

  6. Pounder, R. (1981). Model of medical treatment for duodenal ulcer. Lancet, 1, 29–30

    Article  PubMed  CAS  Google Scholar 

  7. Hood, K. (1988). In Northfield, T.C., Jazrawi, R. and Zentler-Munro, P.L. (eds.) Bile Acids in Health and Disease. Ch. 11. (Lancaster: MTP Press)

    Google Scholar 

  8. Kupfer, R.M., Maudgal, D.P. and Northfield, T.C. (1982). Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet. Dig. Dis. Sci., 27, 1025–29

    Article  PubMed  CAS  Google Scholar 

  9. Maton, P.N., Iser, J.H., Reuben, A., Saxton, H.M., Murphy, G.M. and Dowling, R.H. (1982). The final outcome of CDCA-treatment in 125 patients with radiolucent gallstones: factors influencing efficacy, withdrawal, symptoms and side effects and postdissolution recurrence. Medicine, 61, 85–96

    Article  Google Scholar 

  10. Ruppin, D.C. and Dowling, R.H. (1982). Is recurrence inevitable after gallstone dissolution by bile acid treatment? Lancet, 1, 181–5

    Article  PubMed  CAS  Google Scholar 

  11. Lanzini, A., Jazrawi, R.P. and Northfield, T.C. (1986). Gallstone recurrence after medical dissolution: an over-estimated threat? J. Hepatol, 3, 241–6

    Article  PubMed  CAS  Google Scholar 

  12. Northfield, T.C. and Jasrawi, R.P (1988). Patient selection for bile acid therapy. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds) Bile Acids and the Liver, pp. 329–342, (Lancaster: MTP Press)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Kluwer Academic Publishers

About this chapter

Cite this chapter

Northfield, T.C., Jazrawi, R.P. (1988). Overall Strategy. In: Northfield, T., Jazrawi, R., Zentler-Munro, P. (eds) Bile Acids in Health and Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1249-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1249-6_16

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7054-6

  • Online ISBN: 978-94-009-1249-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics